PRIMA’s Scientific Advisory Board (SAB) consists of three distinguished and high-ranked scientists from Sweden, Denmark and U.S.
The SAB contributes with deep knowledge and experience with building science environments for excellence science and are at the international forefront in their respective fields which are very aligned with the scientific focus of PRIMA.
Prof. Sten Linnarsson
Photo: Ulf Sirborn
Chair of the Department of Medical Biochemistry and Biophysics, Division of Molecular Neurobiology , Karolinska Institutet, Sweden
Prof. Ronald N. Germain
NIH Distinguished Investigator Chief, Laboratory of Immune System Biology, Chief, Lymphocyte Biology Section, Director, Center for Advanced Tissue Imaging (CAT-I), National Institute of Allergy and Infectious Diseases National Institutes of Health, USA
Prof. Sine Hadrup
Head of Sections for Experimental & Translational Immunology, Department of Health Technology, at the Technical University of Denmark
SAB Zero-visit February 2024
Our first SAB meeting took place in February 2024. This zero-visit was used to introduce PRIMA goals and vision and present the expertise and resources available in the Centre. The report from this visit in the initial phase of the Centre serves as a precious guide to develop the further strategies and work in PRIMA.
PRIMA’s Steering Board includes leaders from host and partner institutions
PRIMA is very fortunate to have an extremely skilled and functional steering board. The board members have leading positions within their institutions, and both scientific background within the field of immunology and medical sciences, and experience with other Centres of Excellence in Norway.
Prof. Dag Kvale
Head of Institute of Clinical Medicine, University of Oslo
Prof. Shuo-Wang Qiao
Photo: Øystein Horgmo, UiO
Deputy Head of Institute of Clinical Medicine, University of Oslo
Prof. Kjetil Taskén
Head of Institute for Cancer Research, Oslo University Hospital
Prof. John-Torgils Vaage
Head of Department of Immunology, Oslo University Hospital
In 2024, PRIMA established a User Representative board
The user board will contribute to the quality of research with their insights and experiences, and strengthen trust and collaboration between the Centre and the community.
The current User Representatives in PRIMA have strong background from patient organizations.
One of our recently recruited user representatives, Per Werner Torben Jonsson, sadly passed away this autumn before we could begin our work together. A powerful reminder of the importance of our research and a strong motivation to continue the hard work.
"Research provides future hope for those of us who have extensive experiences with cancer. Precision medicine also offers hope for more direct and gentle treatment. PRIMA can represent a quantum leap into such a future, which we, as users with our experience, can help shape"
Tove Nakken
